FibroBiologics Receives Patent From European Patent Office For Its Gene Therapy For The Regeneration Of Chondrocytes Or Cartilage Type Cells
FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics" or the "Company"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and
FibroBiologics got official approval from Europe to own a special way to fix damaged cartilage in joints using genes. This shows their science is working and protected, which helps build trust in what they're creating.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.